The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression

Background: Optimising treatments for patients with treatment-resistant depression (TRD) is key to reducing the burden of this severe illness. The anti-glucocorticoid medication metyrapone has mixed evidence supporting a role as a possible augmentation treatment in TRD. The degree of treatment resis...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Med
Prif Awduron: Strawbridge, Rebecca, Jamieson, Alzbeta, Hodsoll, John, Ferrier, Ian Nicol, McAllister-Williams, Richard Hamish, Powell, Timothy R., Young, Allan H., Cleare, Anthony J., Watson, Stuart
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7920038/
https://ncbi.nlm.nih.gov/pubmed/33669254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040784
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg